国家重点基础研究发展计划(973项目)(2011CB504903)。
XU Yu-huan
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaXU Yan-feng
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaLIU Ying
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaHUANG Lan
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaLI Yan-hong
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaHAN Yun-lin
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaDENG Wei
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaQIN Chuan
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, ChinaZHU Hua
Institute of Laboratory Animal Science, Chinese Academy of medical Sciences. Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine, Beijing 100021, China目的 探讨视网膜血管铺片技术的改进及在实验动物小鼠, 大鼠, 狗和猴中的应用。方法 应用蛋白酶K-胰蛋白酶联合消化法制备视网膜血管铺片, 行HE及PAS染色观察血管形态, 免疫组化方法观察CD31及VEGF的表达。结果 用改进方法制备的视网膜血管铺片, 血管网完整, 无神经组织残留, 可清晰显示血管走向。各级血管形态清晰, 血管分支清楚完整, 无断裂现象。血管内皮细胞形态清晰。CD31在血管周细胞及内皮细胞均有表达;VEGF主要在内皮细胞表达。结论 改进的视网膜血管铺片技术可成功应用于不同实验动物, 为视网膜血管性疾病的研究提供了重要途径。
Objective To improve the method of retinal vascular preparation and application in experimental animals of mice, rats, dogs and monkeys. Methods The retinal vessels were isolated with proteinase K-trypsin digestion technique. The samples were stained by hematoxylin-eosin(HE) and Periodic-Acid Schiff(PAS). The expression of CD31 and VEGF were detected by immunohistochemistry(IHC). Results The spread sheets of vascular network are complete, and can clearly show the blood vessels. No nerve tissue residue is left. Different levels of vascular morphology are clear. The vascular branches are clear and complete with no fracture. The cell morphology is intact, and the cell nucleus is clearly dispayed. The entire process can be completed in a short time, and has a high success rate. The vascular antigen are successfully retained: Expression of CD31 can be seen in both pericytes and endothelial cells; VEGF is mainly expressed in endothelial cells. Conclusions The improved method is successfully applied in different experimental animals. This approach will provide an important contribution to the retinal vascular disease research.
徐玉环,徐艳峰,刘颖,黄澜,李彦红,韩云林,邓巍,许庆刚,秦川,朱华.视网膜血管铺片技术的改进[J].中国比较医学杂志,2015,25(5):51~53,50.
复制